Piper Therapeutics Company
Drug discovery and development for moderating macrophages, with initial focus on immuno-oncology
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
9/1/2015
Employees Number:
1-10
Funding Status:
Seed
Total Funding:
1295013
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Register and Claim Ownership